Recombinant herpes zoster vaccine (Nanjing Grand Theravac Bio-pharmaceutical)

N/A

Report date: 2025/03/20 09:12:22

Base Information

Drug NameRecombinant herpes zoster vaccine (Nanjing Grand Theravac Bio-pharmaceutical)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsVaricella Zoster Virus Infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New ZealandMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesYuanda Weixin Life Science (Nanjing) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesYuanda Weixin Life Science (Nanjing) Co Ltd
Inactive CompaniesN/A
Active IndicationsVaricella Zoster Virus Infection
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A